Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1992 Dec;55(12):1121–1124. doi: 10.1136/jnnp.55.12.1121

Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage.

R Fogelholm 1, K Eskola 1, T Kiminkinen 1, I Kunnamo 1
PMCID: PMC1015323  PMID: 1479389

Abstract

Forty one (14.2%) of 288 patients with primary intracerebral haemorrhage occurring between September 1985 and December 1989 in Central Finland were on anticoagulant treatment at the onset of symptoms. In a sample of 29,000 subjects from the same population the prevalence of anticoagulant treatment was 1.6% in those aged 40 years or older. The estimated age adjusted odds ratio of being on anticoagulant treatment at the time of primary intracerebral haemorrhage was 6.7 (95% CI from 4.5 to 9.9). The risk was highest during the first year of anticoagulation. Overtreatment (thrombotest value < 5%) was slightly more common among the patients. The haematoma volumes measured from the CT scans were similar in patients on anticoagulant treatment and those not anticoagulated. The case fatality rate during the first week and the mortality during follow up of 32 months were slightly higher, and the functional outcome slightly worse in the anticoagulated group.

Full text

PDF
1121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers G. W. Intensity of anticoagulant treatment and risk of intracerebral hematoma. Stroke. 1990 Dec;21(12):1758–1758. doi: 10.1161/01.str.21.12.1758. [DOI] [PubMed] [Google Scholar]
  2. Bewermeyer H., Hojer C., Szelies B., Haupt W. F., Neveling M., Heiss W. D. Die spontane Ponsblutung. Eine Analyse von 38 Fällen. Nervenarzt. 1988 Nov;59(11):640–646. [PubMed] [Google Scholar]
  3. Fogelholm R., Nuutila M., Vuorela A. L. Primary intracerebral haemorrhage in the Jyväskylä region, central Finland, 1985-89: incidence, case fatality rate, and functional outcome. J Neurol Neurosurg Psychiatry. 1992 Jul;55(7):546–552. doi: 10.1136/jnnp.55.7.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Foulkes M. A., Wolf P. A., Price T. R., Mohr J. P., Hier D. B. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1988 May;19(5):547–554. doi: 10.1161/01.str.19.5.547. [DOI] [PubMed] [Google Scholar]
  5. Franke C. L., de Jonge J., van Swieten J. C., Op de Coul A. A., van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke. 1990 May;21(5):726–730. doi: 10.1161/01.str.21.5.726. [DOI] [PubMed] [Google Scholar]
  6. Helweg-Larsen S., Sommer W., Strange P., Lester J., Boysen G. Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke. 1984 Nov-Dec;15(6):1045–1048. doi: 10.1161/01.str.15.6.1045. [DOI] [PubMed] [Google Scholar]
  7. Inzitari D., Giordano G. P., Ancona A. L., Pracucci G., Mascalchi M., Amaducci L. Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke. 1990 Oct;21(10):1419–1423. doi: 10.1161/01.str.21.10.1419. [DOI] [PubMed] [Google Scholar]
  8. Kase C. S., Robinson R. K., Stein R. W., DeWitt L. D., Hier D. B., Harp D. L., Williams J. P., Caplan L. R., Mohr J. P. Anticoagulant-related intracerebral hemorrhage. Neurology. 1985 Jul;35(7):943–948. doi: 10.1212/wnl.35.7.943. [DOI] [PubMed] [Google Scholar]
  9. Landefeld C. S., Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989 Aug;87(2):144–152. doi: 10.1016/s0002-9343(89)80689-8. [DOI] [PubMed] [Google Scholar]
  10. Lowe G. D. Anticoagulant drugs in the elderly: valuable in selected patients. BMJ. 1988 Nov 12;297(6658):1260, 1262-3. doi: 10.1136/bmj.297.6658.1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mattle H. P. Cerebral haemorrhage and anticoagulants. Ir Med J. 1990 Jun;83(2):44–45. [PubMed] [Google Scholar]
  12. RANKIN J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957 May;2(5):200–215. doi: 10.1177/003693305700200504. [DOI] [PubMed] [Google Scholar]
  13. Scott P. J. Anticoagulant drugs in the elderly: the risks usually outweight the benefits. BMJ. 1988 Nov 12;297(6658):1261–1263. doi: 10.1136/bmj.297.6658.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Thie A., Spitzer K., Lappe H., Kunze K. Prognostische Bedeutung initialer klinischer und apparativer Parameter bei spontanen intrazerebralen Blutungen. Fortschr Neurol Psychiatr. 1988 May;56(5):163–169. doi: 10.1055/s-2007-1001781. [DOI] [PubMed] [Google Scholar]
  15. Wintzen A. R., de Jonge H., Loeliger E. A., Bots G. T. The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol. 1984 Nov;16(5):553–558. doi: 10.1002/ana.410160505. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES